New biotech drug for diabetic foot ulcers

    You'll hear about a new biotech drug for diabetic foot ulcers...called Regranex (becaplermin gel).

    It's being introduced now in the U.S...later in Canada.

    It contains a platelet-derived growth factor to stimulate the growth of new tissue...resulting in a modest increase in healing.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote